Last10K.com

Redhill Biopharma Ltd. (RDHL) SEC Filing 20-F Annual report for the fiscal year ending Wednesday, December 31, 2014

Redhill Biopharma Ltd.

CIK: 1553846 Ticker: RDHL

View differences made from one year to another to evaluate Redhill Biopharma Ltd.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Redhill Biopharma Ltd..

Continue

Assess how Redhill Biopharma Ltd.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Redhill Biopharma Ltd.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2015 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Redhill Biopharma Ltd. provided additional information to their SEC Filing as exhibits

Exhibit 1.1: Underwriting Agreement
Exhibit 4.4: Instruments Defining The Rights Of Security Holders, Including Indentures
Exhibit 4.6: Instruments Defining The Rights Of Security Holders, Including Indentures
Exhibit 4.10: Instruments Defining The Rights Of Security Holders, Including Indentures
Exhibit 4.11: Instruments Defining The Rights Of Security Holders, Including Indentures
Exhibit 4.14: Instruments Defining The Rights Of Security Holders, Including Indentures
Exhibit 4.12: Instruments Defining The Rights Of Security Holders, Including Indentures
Exhibit 4.16: Instruments Defining The Rights Of Security Holders, Including Indentures
Exhibit 4.17: Instruments Defining The Rights Of Security Holders, Including Indentures
Exhibit 4.18: Instruments Defining The Rights Of Security Holders, Including Indentures
Exhibit 4.19: Instruments Defining The Rights Of Security Holders, Including Indentures
Exhibit 4.20: Instruments Defining The Rights Of Security Holders, Including Indentures
Exhibit 4.21: Instruments Defining The Rights Of Security Holders, Including Indentures
Exhibit 4.22: Instruments Defining The Rights Of Security Holders, Including Indentures
Exhibit 4.23: Instruments Defining The Rights Of Security Holders, Including Indentures
Exhibit 4.24: Instruments Defining The Rights Of Security Holders, Including Indentures
Exhibit 4.25: Instruments Defining The Rights Of Security Holders, Including Indentures
Exhibit 4.27: Instruments Defining The Rights Of Security Holders, Including Indentures
Exhibit 12.1: Statement Regarding Calculation Of Ratios
Exhibit 12.2: Statement Regarding Calculation Of Ratios
Exhibit 13: Report To Security Holders
Exhibit 15.1: Letter Regards Unaudited Interim Financial Information
Ticker: RDHL
CIK: 1553846
Form Type: 20-F Annual Report
Accession Number: 0001171843-15-001064
Submitted to the SEC: Thu Feb 26 2015 2:12:28 PM EST
Accepted by the SEC: Thu Feb 26 2015
Period: Wednesday, December 31, 2014
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/rdhl/0001171843-15-001064.htm